Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Najam Awan"'
Publikováno v:
Journal of Applied Hematology, Vol 13, Iss 4, Pp 285-287 (2022)
Hemophilia B is an X-linked inherited bleeding disorder caused by either the absence or reduced biosynthesis of clotting factor IX (FIX). This disorder affects approximately 1 in 30,000 male individuals worldwide. Patients with severe form (FIX
Externí odkaz:
https://doaj.org/article/fdfdfd67a875416cb1a970db36c4ad89
Autor:
Aisha Alkhaaldi, Majid Al Teneiji, Muhammad Khanani, Mustafa Baroudi, Altaf Jamil, Omar Trad, Layla Al Reyami, Najam Awan
Publikováno v:
Applied Clinical Research, Clinical Trials and Regulatory Affairs. 1:176-179
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a516d108ce3057116d8f89cabd53e353
https://doi.org/10.2174/2213476x0103150707122135
https://doi.org/10.2174/2213476x0103150707122135
Autor:
William J. Bommer, Donald J. Weidler, William Grossman, Kenneth F. Hossack, Michael D. Ezekowitz, Jawahar L. Mehta, Udho Thadani, William J. Kostuk, Najam Awan
Publikováno v:
American heart journal. 129(3)
The efficacy and safety of amlodipine, 10 mg, a new long-acting calcium antagonist, was compared with placebo in 103 patients with stable angina pectoris in a multicenter double-blind crossover study. The trial consisted of an initial 2-week single-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1c9732e8a31f518edaeabe42f80a57d
https://pubmed.ncbi.nlm.nih.gov/7872184
https://pubmed.ncbi.nlm.nih.gov/7872184
Publikováno v:
Journal of the American College of Cardiology. 15:A172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee40b7af1e4f7fc041860ad70ffbd887
https://doi.org/10.1016/0735-1097(90)92406-r
https://doi.org/10.1016/0735-1097(90)92406-r
Autor:
Ian Crozier, Kenneth Dickstein, Ewa J. Rucinska, James B. Young, Najam Awan, George Klinger, John G.F. Cleland, Hamid Ikram, Lukas Makris, Martin Frey, Nigel Stephen
Publikováno v:
Scopus-Elsevier
Background The aim of the present study was to assess the short- and long-term effects of multiple doses of the angiotensin II receptor antagonist losartan in heart failure. Methods and Results A multicenter, placebo-controlled, oral, multidose (2.5,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43537e34d382c1cf89b19f93b3d200ee
http://www.scopus.com/inward/record.url?eid=2-s2.0-0028798758&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0028798758&partnerID=MN8TOARS
